BioSpace News Archive

Message Hello Monday written in notebook and cup of coffee on white wooden desk, flat lay

C-suite

No ‘Sunday scaries’: Claire Mazumdar on building Bicara—and knowing when to hand over the reins

Strange and bittersweet. That’s how Claire Mazumdar describes her plan to step down from the top spot at Bicara, a biotech she helped form, and head out on parental leave before transitioning into a new role.

September 30, 2026

·

5 min read

·

Gabrielle Masson

Concept idea of light bulb, creative, imagination, motivation, success, and thinking, surreal conceptual art, 3d illustration, painting artwork.

Opinion

Biopharma needs to reward scientists’ judgment

It’s not enough for organizations to want scientists to think like entrepreneurs. They have to incentivize and reward for that behavior.

September 30, 2026

·

5 min read

·

Joanna Ghayad

Business people presenting a new startup idea in financial sector to investors. Businessman rolls gears. Abstract environment with stairs, business concept 3D rendering

C-suite

Trend of women-led M&A fades in 2026 with just two deals so far

Last year, 11 major M&A deals were signed with women-led biotechs. The industry is nowhere near on track to meet that bar for 2026.

September 30, 2026

·

2 min read

·

Annalee Armstrong

FDA

AstraZeneca buys into Summit, UniQure drops on 4-year data, FDA on a roll

Summit Therapeutics scores a $2 billion equity investment from AstraZeneca to support ivonescimab’s late-stage development; uniQure crashes after four-year data from its Huntington’s disease gene therapy failed to impress; Kyverna Therapeutics brings new light to a struggling CAR T space in autoimmune disease.

September 30, 2026

·

1 min read

·

Jef Akst

Press Releases

CUSABIO Expands Flexible Antibody Expression for AI-Driven Antibody Discovery

September 30, 2026

·

1 min read

Press Releases

Egle Therapeutics Announces Positive Phase 1 Data for EGL-003, Showing Favorable Safety and Selective Treg Expansion in Healthy Volunteer Study